1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Quantitative and qualitative conspicuity assessment
CR Median (IQR) CNR Median (IQR) Visual Score
Best^{^a} Intermediate Worst
All CELs (n = 54) 
    3D-IR GRE MPRAGE 80.88 (43.71–125.65) 10.02 (5.71–16.06) 15 (27.8%) 26 (48.1%) 13 (24.1%)
    3D-TSE SPACE 100.92^{^b,^c} (73–191.59) 19.17^{^b,^c} (13.21–36.01) 54 (100%) 0 0
    3D-GRE VIBE 85.86^{^b,^c} (43.71–135.22) 16.76^{^b,^c} (11–37.22) 24 (44.4%)^{^b} 25 (46.3%) 5 (9.3%)^{^b}
Gliomas (n = 38) 
    3D-IR GRE MPRAGE 90.01 (48.29–125.21) 10.51 (5.68–17.33) 9 (23.7%) 19 (50%) 10 (26.3%)
    3D-TSE SPACE 125.64^{^b,^c} (88.41–187.45) 24.46^{^b,^c} (12.55–41.23) 38 (100%) 0 0
    3D-GRE VIBE 94.19^{^b,^c} (58.34–88.95) 16.22^{^d,^c} (9.89–27.25) 16 (42.1%)^{^d} 18 (47.4%) 4 (10.5%)^{^d}
Metastases (n = 16) 
    3D-IR GRE MPRAGE 54.71 (35.24–130.01) 9.30 (6.77–12.29) 6 (37.5%) 7 (43.8%) 3 (18.8%)
    3D-TSE SPACE 80.04^{^b,^c} (63.13–200) 17.15^{^b,^c} (13.63–21.26) 16 (100%) 0 0
    3D-GRE VIBE 72.95^{^b,^c} (54.19–154.43) 17.26^{^b,^c} (12.14–31.18) 8 (50%) 7 (43.8%) 1 (6.3%)
Note:—IR indicates inversion recovery; GRE, gradient recalled-echo; CR, contrast rate; CNR, contrast-to-noise ratio; IQR, interquartile range.
↵a Because SPACE in the visual assessment was constantly rated as best in all cases, no statistical comparison tests were performed in this analysis.
↵b P < .001.
↵c P ≤ .01 (adjusted for the order of sequence acquisition; FSL General Linear Model).
↵d P = .001 (compared with MPRAGE, Wilcoxon test).